Shares of drugmakers involved in Ebola treatments rose Friday after increasing concerns regarding the CDC’s confirmation of the first imported case of Ebola diagnosed in the U.S.
On Friday, Lakeland Industries Inc. (LAKE) printed a higher than average trading volume with the issue trading 2.4M shares, compared to the average volume of 258,031. The stock began trading at $8.59 to finish the session up 4.32% from the prior days close of $8.34. On an intraday basis it got as low as $8.16 and as high as $8.90.
On valuation-measures, shares of Lakeland Industries has a price/book and price/sales ratio of 0.48 and 0.95, respectively. T-12 profit margin is (4.12%), while EPS registers at ($0.65). The company has a market cap of $46.63M and a trailing-12 revenue of more than $93M.
On trading-measure, LAKE has a beta of -0.16 and a short float of 0.17%. In the past 52 weeks, shares of protective medical equipment maker have traded between a low of $4.75 and a high of $9.80 with the 50-day MA and 200-day MA located at $6.80 and $6.82 levels, respectively.
LAKE currently prints a one year return of about 59.93% and a year-to-date return of around 65.40%.
Sarepta Therapeutics, Inc. (SRPT) gained $1.67 to $23.30 Friday. Approximately 2,201,954 shares changed hands, compared to the stock’s average daily volume of 1,518,450 shares.
On valuation-measures, shares of Sarepta Therapeutics have a P/E to growth ratio of -0.65 and EPS of ($3.03). The company has a market cap of $953.51M and a median Wall Street price target of $36.50 with a high target of $63.00.
On trading-measure, SRPT has a beta of 0.74 and a short float of 33.81%. In the past 52 weeks, shares of Cambridge, Massachusetts-based biopharmaceutical company have traded between a low of $12.12 and a high of $55.61 with the 50-day MA and 200-day MA located at $22.36 and $26.84 levels, respectively.
SRPT currently prints a one year loss of about 54.03% and a year-to-date return of around 14.38%.
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!